Categories AlphaGraphs, Earnings, Health Care
Walgreens Boots Alliance (WBA) Q4 2023 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2023 earnings results today.
Sales increased 9.2% year-over-year to $35.4 billion. Sales growth was 8.3% on a constant currency basis. The top line increase was driven by growth in the US Retail Pharmacy and International segments, and sales contribution from the US Healthcare segment.
Net loss was $180 million, or $0.21 per share, compared to a loss of $415 million, or $0.48 per share, last year. Adjusted EPS decreased 17% to $0.67.
The company expects adjusted EPS of $3.20-3.50 in fiscal year 2024.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
